Clinical Trial Update: A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of oxaliplatin plus 5-fluorouracil in patients with recurrent ovarian cancer, with the study status reported as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Ovarian Carcinoma, Relapse | Phase 2 | Status: COMPLETED